Literature DB >> 15296521

Assessing psychopathology in individuals with developmental disabilities.

Karena S Rush1, Lynn G Bowman, Shannon L Eidman, Lisa M Toole, Bruce P Mortenson.   

Abstract

Individuals with developmental disabilities are at high risk for developing mental health problems. The prevalence of psychopathology is approximately 4 times higher than that found in the general population. Yet there is a tendency to underdiagnose psychiatric disorders in the developmentally delayed population because of diagnostic overshadowing, the lack of appropriate diagnostic criteria, and the paucity of appropriate assessment measures. Over the past decade, there has been an emergence of scales developed specifically to screen for psychopathology in individuals with developmental disabilities. In addition, advancements have been made in observation techniques, thus facilitating the ability to objectively observe behaviors often described as internal events. A description of a multimethod approach to assessing psychopathology in individuals with developmental disabilities is provided incorporating the recent advancements in the field, as well as suggestions for future research.

Entities:  

Mesh:

Year:  2004        PMID: 15296521     DOI: 10.1177/0145445503259830

Source DB:  PubMed          Journal:  Behav Modif        ISSN: 0145-4455


  14 in total

Review 1.  Suicide risk in youth with intellectual disabilities: the challenges of screening.

Authors:  Erica Ludi; Elizabeth D Ballard; Rachel Greenbaum; Maryland Pao; Jeffrey Bridge; William Reynolds; Lisa Horowitz
Journal:  J Dev Behav Pediatr       Date:  2012-06       Impact factor: 2.225

2.  Increased sexual aggression following ziprasidone discontinuation in an intellectually disabled adult man.

Authors:  Nancy C Brahm; Gary A Fast
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2009

3.  Characterizing psychiatric comorbidity in children with autism spectrum disorder receiving publicly funded mental health services.

Authors:  Lauren Brookman-Frazee; Nicole Stadnick; Colby Chlebowski; Mary Baker-Ericzén; William Ganger
Journal:  Autism       Date:  2017-09-15

4.  Behavior and adaptive functioning in adolescents with Down syndrome: specifying targets for intervention.

Authors:  Lisa M Jacola; Francis Hickey; Steven R Howe; Anna Esbensen; Paula K Shear
Journal:  J Ment Health Res Intellect Disabil       Date:  2014-10-03

5.  Involvement of Youths with Autism Spectrum Disorders or Intellectual Disabilities in Multiple Public Service Systems.

Authors:  Lauren Brookman-Frazee; Mary Baker-Ericzén; Aubyn Stahmer; David Mandell; Rachel A Haine; Richard L Hough
Journal:  J Ment Health Res Intellect Disabil       Date:  2009-07-01

6.  Case Report: A Case of Intellectual Disability with Inappropriate and Challenging Sexual Behavior that was Treated with GNRH Analogues.

Authors:  Ferhat Yaylacı; Ali Gül
Journal:  Psychopharmacol Bull       Date:  2020-05-19

7.  Evaluation of serum prolactin levels in intellectually disabled patients using antipsychotic medications.

Authors:  Tammy L Lambert; Kevin C Farmer; Nancy C Brahm
Journal:  Int J Endocrinol Metab       Date:  2012-12-21

8.  Links between Autism Spectrum Disorder Diagnostic Status and Family Quality of Life.

Authors:  Andrew G McKechanie; Vivien J Moffat; Eve C Johnstone; Sue Fletcher-Watson
Journal:  Children (Basel)       Date:  2017-04-03

9.  Establishing priorities for psychological interventions in pediatric settings: A decision-tree approach using the DISABKIDS-10 Index as a screening instrument.

Authors:  Neuza Silva; Monika Bullinger; Helena Moreira; Maria Cristina Canavarro; Carlos Carona
Journal:  PLoS One       Date:  2018-05-31       Impact factor: 3.240

10.  Associations between Psychological Problems and Quality of Life in Pediatric Short Stature from Patients' and Parents' Perspectives.

Authors:  Julia Hannah Quitmann; Monika Bullinger; Rachel Sommer; Anja Christine Rohenkohl; Neuza Maria Bernardino Da Silva
Journal:  PLoS One       Date:  2016-04-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.